You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR VILTOLARSEN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VILTOLARSEN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04060199 ↗	Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)	Recruiting	Nippon Shinyaku Co., Ltd.	Phase 3	2020-04-14	The main objective of this study is to evaluate the efficacy of Viltolarsen compared to placebo in Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping.
NCT04060199 ↗	Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)	Recruiting	NS Pharma, Inc.	Phase 3	2020-04-14	The main objective of this study is to evaluate the efficacy of Viltolarsen compared to placebo in Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping.
NCT04687020 ↗	Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)	Recruiting	NS Pharma, Inc.	Phase 4	2021-06-10	The VILT-502 study is Non-interventional Study(United States)/Low-intervention Clinical Trial (Canada) of Viltolarsen administered intravenously once weekly for 10 years to boys with DMD who complete the NS-065/NCNP-01-202 study.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VILTOLARSEN

Condition Name

Chart
Table

Condition Name for VILTOLARSEN
Intervention	Trials
Duchenne Muscular Dystrophy	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VILTOLARSEN
Intervention	Trials
Muscular Dystrophy, Duchenne	4
Muscular Dystrophies	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VILTOLARSEN

Trials by Country

Map
Table

Trials by Country for VILTOLARSEN
Location	Trials
United States	5
Spain	3
Italy	3
Turkey	3
Japan	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VILTOLARSEN
Location	Trials
Virginia	2
Oregon	1
Illinois	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VILTOLARSEN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VILTOLARSEN
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	2
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VILTOLARSEN
Clinical Trial Phase	Trials
Recruiting	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VILTOLARSEN

Sponsor Name

Chart
Table

Sponsor Name for VILTOLARSEN
Sponsor	Trials
NS Pharma, Inc.	4
Nippon Shinyaku Co., Ltd.	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VILTOLARSEN
Sponsor	Trials
Industry	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.